Table 1 Patient and treatment characteristics of patients enrolled in the present study
From: Dosimetric impact of variable bladder filling on IMRT planning for locally advanced carcinoma cervix
Characteristics | N (%) |
|---|---|
Age (mean+SD) | 53.15 ± 10.61 (range, 30–79 years) |
Parity (1:2:3:4:5:6) | 2(5%): 4(10%): 10(25%): 15(37.50%): 6(15%): 3(7.50%) |
ECOG performance status (0:1:2) | 5 (12.5%): 25 (63.5%): 10 (25%) |
FIGO tumor stage (IIA:IIB:IIIA:IIIB:IVA) | 4(10%): 17(42.50%): 4(10%): 14(35%): 1(2.50%) |
Grade (I:II:III) | 10(25%): 25(63.5%): 5(12.5%) |
Pelvic lymphnodes (present: absent) | 28 (70%): 12 (30%) |
Bulky disease (> 4 cm) (present: absent) | 30 (75%): 10 (25%) |
External beam radiotherapy dose (PTV D95%) | Mean 49.76 Gy + 1.29 Gy (range, 44.91–51.33 Gy) |
Concurrent chemotherapy (cisplatin: carboplatin) | 32 (80%):8(20%) |